Effective treatments are required for patients with diffuse...

Hematological Oncology 2017 / 06 Vol. 35

Effective treatments are required for patients with diffuse large B-cell lymphoma (DLBCL) with primary refractory disease

Salas, Q.Q., Domingo Domenech, E., Mercadal, S., Oliveira, A., Aguilera, C., De la Banda, E., Climent, F., Lucas, A., Garcia, N., Baca, C., Fernandez de Sevilla, A., Sureda, A., González Barca, E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2439_92
Date:
June, 2017
File:
PDF, 92 KB
english, 2017
Conversion to is in progress
Conversion to is failed